# Biktarvy

NDC: 61958-2501
Generic name: bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
Labeler / Manufacturer: Gilead Sciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20180207

FDA application: NDA210251

## Active ingredients

- BICTEGRAVIR SODIUM: 50 mg/1
- EMTRICITABINE: 200 mg/1
- TENOFOVIR ALAFENAMIDE FUMARATE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-2501"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-2501
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=664cb8f0-1f65-441b-b0d9-ba3d798be309